2022
DOI: 10.1111/hae.14516
|View full text |Cite
|
Sign up to set email alerts
|

Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH)

Abstract: Introduction Gene therapy (GT) is becoming a realistic treatment option for patients with haemophilia. Outside clinical trials, the complexity and potential complications of GT will pose unprecedented challenges to haemophilia care centres. Aim To explore the potential use of electronic tools to improve the delivery of GT under real‐world conditions. Methods Considering the hub‐and‐spoke model, the GTH working group on GT considered the entire patient pathway and reached consensus on requirements for an integr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(11 citation statements)
references
References 18 publications
1
8
0
2
Order By: Relevance
“…To date, tumor diseases have been occurred in four patients after gene therapy. 21 37 38 39 40 The comprehensive clinical, histopathologic, and molecular genetic reappraisal of these cases revealed no evidence of a causal relationship with the gene therapy. Similarly, a comprehensive molecular genetic reappraisal should be initiated in future cases of tumors after gene therapy.…”
Section: Monitoring and Management Of Side Effects After Gene Therapymentioning
confidence: 97%
See 4 more Smart Citations
“…To date, tumor diseases have been occurred in four patients after gene therapy. 21 37 38 39 40 The comprehensive clinical, histopathologic, and molecular genetic reappraisal of these cases revealed no evidence of a causal relationship with the gene therapy. Similarly, a comprehensive molecular genetic reappraisal should be initiated in future cases of tumors after gene therapy.…”
Section: Monitoring and Management Of Side Effects After Gene Therapymentioning
confidence: 97%
“…Checklists can help to collect the required findings and other documentation at the referring center (spoke) before introduction of the patient to the dosing center (hub). 41 These are documented in the applica-tion as in a file and, with the patient's consent, shared with the hub center even before a presentation. In this way, unnecessary duplicate examinations and drives to the dispensing center can be reduced.…”
Section: Use Of Electronic Applicationsmentioning
confidence: 99%
See 3 more Smart Citations